D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 47 Citations 11,102 133 World Ranking 14499 National Ranking 1069

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • DNA

His primary scientific interests are in Pathology, Frontotemporal lobar degeneration, Amyotrophic lateral sclerosis, Alpha-synuclein and Ubiquitin. His work in Pathology addresses subjects such as Immunoblot Analysis, which are connected to disciplines such as Degenerative disease, Hippocampal formation, Alternative splicing and Frontotemporal dementia. His Amyotrophic lateral sclerosis research is multidisciplinary, relying on both Neurite, Molecular biology, Motor neuron and Phosphorylation.

Takashi Nonaka interconnects UBQLN2, Cellular differentiation, Charged multivesicular body protein 2B, TARDBP and Anatomy in the investigation of issues within Motor neuron. His research in Alpha-synuclein intersects with topics in Fibril, Dementia with Lewy bodies, Intracellular and Pharmacology. His Ubiquitin study is focused on Biochemistry in general.

His most cited work include:

  • TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis (1717 citations)
  • Prion-like spreading of pathological α-synuclein in brain (489 citations)
  • Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. (452 citations)

What are the main themes of his work throughout his whole career to date?

Takashi Nonaka mostly deals with Cell biology, Biochemistry, Intracellular, Pathology and Molecular biology. His Cell biology research includes elements of Fibril, In vitro, Ubiquitin and Alpha-synuclein. Takashi Nonaka combines subjects such as Dementia with Lewy bodies and Neurite with his study of Fibril.

His study in Frontotemporal lobar degeneration, Amyotrophic lateral sclerosis, Frontotemporal dementia, Immunohistochemistry and Corticobasal degeneration is carried out as part of his studies in Pathology. His Frontotemporal lobar degeneration study also includes

  • Phosphorylation, which have a strong connection to Inclusion bodies,
  • Neurodegeneration which connect with Mutant. The study incorporates disciplines such as Phenotype, Motor neuron, Antibody and Prion protein in addition to Amyotrophic lateral sclerosis.

He most often published in these fields:

  • Cell biology (35.86%)
  • Biochemistry (21.38%)
  • Intracellular (17.24%)

What were the highlights of his more recent work (between 2015-2021)?

  • Cell biology (35.86%)
  • Protein aggregation (9.66%)
  • In vitro (11.72%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cell biology, Protein aggregation, In vitro, Neurodegeneration and Fibril. His Cell biology research is multidisciplinary, incorporating elements of α synuclein, Alpha-synuclein, Pathogenesis and In vivo. His biological study deals with issues like Ubiquitin, which deal with fields such as Phosphorylation, Mutation and Mutant.

His study in In vitro is interdisciplinary in nature, drawing from both Cell, Peptide sequence and Amyloid. His Neurodegeneration research integrates issues from Phenotype, Frontotemporal lobar degeneration, Intracellular and Ataxin. The Fibril study combines topics in areas such as Dementia with Lewy bodies and Neurite.

Between 2015 and 2021, his most popular works were:

  • Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau (103 citations)
  • Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils. (51 citations)
  • The Effect of Fragmented Pathogenic α-Synuclein Seeds on Prion-like Propagation (48 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • DNA

The scientist’s investigation covers issues in Neurodegeneration, Fibril, Protein aggregation, Amyloid and Biochemistry. The various areas that Takashi Nonaka examines in his Neurodegeneration study include Cerebellum, Dentate gyrus, Hippocampal formation, Frontotemporal dementia and Anterior Horn Cell. His research integrates issues of Neurite and Function in his study of Fibril.

His work deals with themes such as Mutation, Ubiquitin, Lysosome and Mutant, which intersect with Protein aggregation. His research in Ubiquitin intersects with topics in Casein Kinase Idelta, Casein kinase 1, Molecular biology, Intracellular and Phosphorylation. His research is interdisciplinary, bridging the disciplines of Frontotemporal lobar degeneration and Biochemistry.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Tetsuaki Arai;Masato Hasegawa;Haruhiko Akiyama;Kenji Ikeda.
Biochemical and Biophysical Research Communications (2006)

3131 Citations

Prion-like spreading of pathological α-synuclein in brain

Masami Masuda-Suzukake;Takashi Nonaka;Masato Hosokawa;Takayuki Oikawa.
Brain (2013)

743 Citations

Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Masato Hasegawa;Tetsuaki Arai;Takashi Nonaka;Fuyuki Kametani.
Annals of Neurology (2008)

644 Citations

Drug screening for ALS using patient-specific induced pluripotent stem cells.

Naohiro Egawa;Shiho Kitaoka;Kayoko Tsukita;Motoko Naitoh.
Science Translational Medicine (2012)

568 Citations

Phosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy Lesions

Masato Hasegawa;Hideo Fujiwara;Takashi Nonaka;Koichi Wakabayashi.
Journal of Biological Chemistry (2002)

442 Citations

Small Molecule Inhibitors of α-Synuclein Filament Assembly†

Masami Masuda;Nobuyuki Suzuki;Sayuri Taniguchi;Takayuki Oikawa.
Biochemistry (2006)

422 Citations

Seeded Aggregation and Toxicity of α-Synuclein and Tau: CELLULAR MODELS OF NEURODEGENERATIVE DISEASES*

Takashi Nonaka;Sayuri T. Watanabe;Takeshi Iwatsubo;Masato Hasegawa.
Journal of Biological Chemistry (2010)

370 Citations

Prion-like Properties of Pathological TDP-43 Aggregates from Diseased Brains

Takashi Nonaka;Masami Masuda-Suzukake;Tetsuaki Arai;Tetsuaki Arai;Yoko Hasegawa.
Cell Reports (2013)

367 Citations

Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43

Takashi Nonaka;Fuyuki Kametani;Tetsuaki Arai;Haruhiko Akiyama.
Human Molecular Genetics (2009)

327 Citations

Supramolecular structure of the Shigella type III secretion machinery: the needle part is changeable in length and essential for delivery of effectors

Koichi Tamano;Shin‐Ichi Aizawa;Eisaku Katayama;Takashi Nonaka.
The EMBO Journal (2000)

295 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Takashi Nonaka

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 104

Virginia M.-Y. Lee

Virginia M.-Y. Lee

University of Pennsylvania

Publications: 101

Dennis W. Dickson

Dennis W. Dickson

Mayo Clinic

Publications: 85

Masato Hasegawa

Masato Hasegawa

Tokyo Metropolitan Institute of Medical Science

Publications: 82

Emanuele Buratti

Emanuele Buratti

International Centre for Genetic Engineering and Biotechnology

Publications: 60

Glenda M. Halliday

Glenda M. Halliday

University of Sydney

Publications: 55

Manuela Neumann

Manuela Neumann

University of Tübingen

Publications: 55

Tiago F. Outeiro

Tiago F. Outeiro

University of Göttingen

Publications: 52

Rosa Rademakers

Rosa Rademakers

Mayo Clinic

Publications: 50

Akiyoshi Kakita

Akiyoshi Kakita

Niigata University

Publications: 50

Koichi Wakabayashi

Koichi Wakabayashi

Hirosaki University

Publications: 48

Ian R. Mackenzie

Ian R. Mackenzie

University of British Columbia

Publications: 46

Leonard Petrucelli

Leonard Petrucelli

Mayo Clinic

Publications: 45

Michael J. Strong

Michael J. Strong

University of Michigan–Ann Arbor

Publications: 41

Christopher Shaw

Christopher Shaw

King's College London

Publications: 40

Christian Haass

Christian Haass

Ludwig-Maximilians-Universität München

Publications: 40

Trending Scientists

Scott Klasky

Scott Klasky

Oak Ridge National Laboratory

Samuel Kortum

Samuel Kortum

Yale University

Craig William Fellenstein

Craig William Fellenstein

IBM (United States)

Atsuo Kawamura

Atsuo Kawamura

Yokohama National University

Aristide F. Massardo

Aristide F. Massardo

University of Genoa

Tomas Nylander

Tomas Nylander

Ericsson (Sweden)

Antonio Otero

Antonio Otero

University of Castilla-La Mancha

Hong Zhang

Hong Zhang

University of Amsterdam

Yoshiyuki Inaguma

Yoshiyuki Inaguma

Gakushuin University

Claus Bässler

Claus Bässler

Goethe University Frankfurt

Graham Jewitt

Graham Jewitt

IHE Delft Institute for Water Education

Rodrigo Correa-Oliveira

Rodrigo Correa-Oliveira

Oswaldo Cruz Foundation

Kenji Wakai

Kenji Wakai

Nagoya University

Vivianna M. Van Deerlin

Vivianna M. Van Deerlin

University of Pennsylvania

Timothy Caulfield

Timothy Caulfield

University of Alberta

Bhaskar Dutta

Bhaskar Dutta

Texas A&M University

Something went wrong. Please try again later.